OGF, 7

General Information


DRACP ID  DRACP00158

Peptide Name   OGF, 7

Sequence  YGGFM

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  The native opioid growth factor

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HEp-2 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 5.2% inhibition at 10-6 M, 4.5% inhibition at 10-5 M, 2.4% inhibition at 10-4 M, 3.3% inhibition at 10-3 M MTT assay 72 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 2.3% inhibition at 10-6 M, 11.4% inhibition at 10-5 M, 12% inhibition at 10-4 M, 22.3% inhibition at 10-3 M MTT assay 72 h 1
HBL Melanoma Carcinoma 0.4% inhibition at 10-6 M, 1% inhibition at 10-5 M, 4.5% inhibition at 10-4 M, 10.8% inhibition at 10-3 M MTT assay 72 h 1
HT-29 Colon adenocarcinoma Carcinoma 14% inhibition at 10-6 M, 15.9% inhibition at 10-5 M, 16.1% inhibition at 10-4 M, 19.3% inhibition at 10-3 M MTT assay 72 h 1
SW620 Colon adenocarcinoma Carcinoma 18.9% inhibition at 10-6 M, 12.7% inhibition at 10-5 M, 15.3% inhibition at 10-4 M, 19.1% inhibition at 10-3 M MTT assay 72 h 1
CaCo-2 Colon adenocarcinoma Carcinoma 4.2% inhibition at 10-6 M, 6.4% inhibition at 10-5 M, 8.4% inhibition at 10-4 M, 3.2% inhibition at 10-3 M MTT assay 72 h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma 3.6% inhibition at 10-6 M, 4.1% inhibition at 10-5 M, 7.6% inhibition at 10-4 M, 15.4% inhibition at 10-3 M MTT assay 72 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  lead to apoptosis

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00158

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C27H35N5O7S

Absent amino acids  ACDEHIKLNPQRSTVW

Common amino acids  G

Mass  64519

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  707

Hydrophobicity  52

Aliphatic Index  0

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  372.5

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16722632

Title  Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity

Doi 10.1021/jm051026

Year  +2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.